Beschreibung
Gut microbiome composition analysis in berberine-treated NAFLD models reveals shifts toward beneficial bacterial populations, supporting the gut-liver axis as a mechanism for berberine's hepatoprotective effects.
Figure 23
ChartSource Paper
Berberine Effects in Pre-Fibrotic Stages of Non-Alcoholic Fatty Liver Disease-Clinical and Pre-Clinical Overview and Systematic Review of the Literature.Cite This Figure
![Figure 23: Gut microbiome composition analysis in berberine-treated NAFLD models reveals shifts toward beneficial bacterial populations, supporting the gut-liver axis as a mechanism for berberine's hepatoprotective effects.]() > Source: Florentina Ionita-Radu et al. "Berberine Effects in Pre-Fibrotic Stages of Non-Alcoholic Fatty Liver Disease-Cl." *International journal of molecular sciences*, 2024. PMID: [38673787](https://pubmed.ncbi.nlm.nih.gov/38673787/)
<figure> <img src="" alt="Gut microbiome composition analysis in berberine-treated NAFLD models reveals shifts toward beneficial bacterial populations, supporting the gut-liver axis as a mechanism for berberine's hepatoprotective effects." /> <figcaption>Figure 23. Gut microbiome composition analysis in berberine-treated NAFLD models reveals shifts toward beneficial bacterial populations, supporting the gut-liver axis as a mechanism for berberine's hepatoprotective effects.<br> Source: Florentina Ionita-Radu et al. "Berberine Effects in Pre-Fibrotic Stages of Non-Alcoholic Fatty Liver Disease-Cl." <em>International journal of molecular sciences</em>, 2024. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/38673787/">38673787</a></figcaption> </figure>